netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
Notes:
Please also refer to the Cancer Drugs Fund list
 Details...
08.04  Expand sub section  Miscellaneous preparations
 note 
Acid citrate glucose infusion

Restricted Drug Unlicensed
Red
Anticoagulant used during apheresis
   
Cold storage solution

Restricted Drug Unlicensed
Red
Perfusion solution for liver grafts from Non Heart Beating Donors
   
Indocyanine green (ICG) dye

Restricted Drug Unlicensed
Red
Added to 9mTc nanocolloid to improve detection of sentinel nodes. 50 microlitres of 5 mg/mL injected at tumour site, 2 hours before surgery
   
Intrinsic factor caps

Restricted Drug Unlicensed
Red
Part 2 of Schilling test for vitamin B12 deficiency
   
Muromonab-CD3 injection (monoclonal (OKT3))

Restricted Drug Unlicensed
Red
Liver and renal graft rejection
   
 ....
Key
note Notes First Choice Item First Choice item
Section Title Section Title (top level) Non Formulary Item Non Formulary section
Section Title Section Title (sub level)
Cytotoxic Drug
Cytotoxic Drug
Restricted Drug
Restricted Drug
CD
Controlled Drug
Unlicensed Drug
Unlicensed
High Cost Medicine
High Cost Medicine
click to search medicines.org.uk
Link to SPCs
click to search medicines.org.uk
Link to adult BNF
Track Changes
Display tracking information
click to search medicines.org.uk
Cancer Drugs Fund
Cancer Drugs Fund
   

 

Traffic Light Status Information

Status Description
  Red   Specialist Prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   
  Amber 1   Treatment can be initiated in primary care after a recommendation from an appropriate specialist  
  Amber 2   Specialist initiation followed by maintenance prescribing in primary care  
  Amber 3   Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  
  Green   Specialist and non-specialist initiation  
  Grey   Not recommended for prescribing  

netFormulary